Exploring how certain enzymes create important drug components.
Understanding How Nonheme Iron-Dependent Enzymes Assemble Pharmacophores: Studies of Cyclopropane, Aziridine, and Isonitrile Formation
This study is exploring how certain enzymes that rely on non-heme iron can help create special chemical structures important for making new medicines, focusing on finding and understanding these enzymes to improve drug development.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Carolina State University Raleigh NIH-funded |
| Lab location | 1 site (Raleigh, United States) |
| Project ID | NIH-10803794 on NIH RePORTER |
What this research studies
This research investigates the role of non-heme iron-dependent enzymes in the formation of unique chemical structures that are crucial for drug development. By utilizing advanced bioinformatics and biochemical techniques, the project aims to identify and characterize enzymes that can produce cyclopropanes, aziridines, and isonitriles, which are valuable pharmacophores in medicinal chemistry. The approach combines computational analysis with experimental validation to uncover the functions of these enzymes, potentially leading to new methods for synthesizing complex drug molecules.
Who could benefit from this research
Good fit: Patients who may benefit from this research include those with conditions that could be treated by new drugs developed from the identified enzyme pathways.
Not a fit: Patients who are not affected by diseases that could be treated with the new drug compounds may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective drugs for various diseases.
How similar studies have performed: Other research has shown promise in utilizing enzyme-based approaches for drug development, indicating that this strategy has potential for success.
Where this research is happening
Raleigh, United States
- North Carolina State University Raleigh — Raleigh, United States (Active)
Researchers
- Principal investigator: Chang, Wei-Chen — North Carolina State University Raleigh
- Study coordinator: Chang, Wei-Chen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.